Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

Summary

This trial is designed to evaluate whether low-dose colchicine, in addition to standard treatment recommended by guidelines, further reduces the risk of major adverse cardiovascular events in patients with acute coronary syndromes (ACS) through a prospective, randomized, double-blind, placebo-controlled clinical trial.

Timeline

Start

2024-09-02

Primary completion

2027-02

Completion

2028-06

Drugs

Indications